Browse the full archive, newest first.
In a significant move to enhance its oncology pipeline, Johnson & Johnson has announced the acquisition of Firefly Bio for $1 billion, focusing on KRAS inhibitors.
Recent updates indicate that Planned Parenthood is experiencing closures and changes in its participation in the Title X program due to significant policy shifts and funding reductions.
An early-stage trial has shown a strong response rate for a combination of pancreatic cancer drugs developed by Tango Therapeutics and Revolution Medicines.
Berkshire Hathaway's success is often attributed to its substantial cash reserves, but there are other significant assets that contribute to its performance.
LibertyStream has achieved a notable milestone by delivering its first tonne of lithium carbonate, marking a significant step in its operations within the lithium market.